This often means looking beyond traditional medicine and incorporating innovative therapies that align with our mission of promoting optimal health
that GlyNAC cures diseases
Your Action Plan for Optimal Benefits: Be Consistent: Aim for consistent daily intake
Athiras lead clinical candidate, fosgonimeton (formerly ATH-1017 / NDX-1017), is a structurally distinct phosphate prodrug of Dihexa not Dihexa itself
Given the unclear etiology of fibromyalgia, and the heterogeneous presentations of the disease, it has become clear that no one therapy is broadly efficacious
Possible side effects Side effects can vary and may include: Injection-site irritation (redness, tenderness, swelling) Headache, fatigue, or dizziness (reported anecdotally/observationally) Digestive discomfort in some individuals Contraindications & precautions BPC-157 may not be appropriate for everyone